Analysis of host immune responses involved in control of HIV infections
Analysis of host immune responses involved in control of HIV infections
批准号:
16017221
负责人:
MATANO Tetsuro
金额:
$9.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the natural courses of HIV infections, cytotoxic T lymphocyte (CTL) responses play a central role in resolution from primary infection but fail to control viral replication leading to establishment of persistent HIV infection. We have been examining the effect of vaccine-induced CTL responses on simian immunodeficiency virus (SIV) replication in macaques to elucidate the mechanism for persistent HIV infection. We have found a group of rhesus macaques sharing a major histocompatibility complex haplotype 90-120-a that show vaccine-based SIV control. Some of them have shown reappearance of plasma viremia after 1-year of viral control with accumulation of Gag CTL escape mutations. In this study, we have examined the replicative ability of SIV with these multiple CTL escape mutations.The mutant SIV had Gag mutations escaping from three epitope-specific CTLs and showed diminished replicative ability in vitro compared to the wild-type SIV and the SW with a single CTL escape mutation rapidly-selected in the early phase of infection. This indicates that the viruses reappeared by escaping from CTLs with viral fitness costs, suggesting involvement of these three epitope-specific CTL responses in viral control. Viral evasion from immune control with a single escape mutation from a dominant CTL has been reported only in one preclinical AIDS vaccine trial in an acute AIDS model (Nature 415 : 335, 2002). This report has not made it clear whether multiple epitope-specific CTLs can be involved in the vaccine-based control of immunodeficiency virus replication, but our results indicate that accumulation of multiple CTL escape mutations can result in viral breakthrough from the vaccine-based control of SIV replication.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Influence of glycosylation on the efficacy of an Env-based vaccine against SIVmac239 in a macaque AIDS model.
在猕猴艾滋病模型中,糖基化对基于 Env 的 SIVmac239 疫苗功效的影响。
DOI:
--
发表时间:
2005
期刊:
J.Virol. 79(16):
影响因子:
--
作者:
[Mori, K., Sugimoto, C., Ohgimoto, S., Shioda, 'T., Takebe, Y., Nagai, Y.et al.]
通讯作者:
Y.et al.
Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
在猿猴艾滋病模型的慢性期通过树突状细胞疫苗接种刺激病毒特异性 T 细胞反应。
DOI:
--
发表时间:
2004
期刊:
Jpn.J.Infect.Dis. 57・5
影响因子:
--
作者:
[Moriaki Kato, et al.]
通讯作者:
et al.
Influenee of glycosylation on the efficacy of an Env-based vaccine against SIVmac239 in a macaque AIDS model.
在猕猴艾滋病模型中糖基化对基于 Env 的 SIVmac239 疫苗功效的影响。
DOI:
--
发表时间:
2002
期刊:
J.Virol. 79(16)
影响因子:
--
作者:
[Kazuyasu Mori, et al.]
通讯作者:
et al.
DOI:
10.1099/vir.0.79890-0
发表时间:
2004-07-01
期刊:
JOURNAL OF GENERAL VIROLOGY
影响因子:
3.8
作者:
[Lun, WH, Takeda, A, Matano, T]
通讯作者:
Matano, T
DOI:
10.1128/jvi.79.17.11529-11532.2005
发表时间:
2005-09-01
期刊:
JOURNAL OF VIROLOGY
影响因子:
5.4
作者:
[Kobayashi, M, Igarashi, H, Matano, T]
通讯作者:
Matano, T
共 8 条
Analysis of efficacy of a vaccine inducing confined avirulent virus replication against immunodeficiency virus infection
-
批准号:20390131
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.73万
-
财政年份:2008
-
负责人:MATANO Tetsuro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
FGF21通过CTL1介导的胆碱稳态调控线粒体自噬对帕金森病的保护机制研究
-
批准号:MS25H310003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李晨
-
依托单位:
S1P诱导LSEC分泌IL-12调控HBV特异性CTL应答的机制及作为HBeAg阴性慢性乙型肝炎急性发作分型标志物的研究
-
批准号:2025JJ50652
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴伟民
-
依托单位:
CD4+ CTL通过杀伤抗原呈递细胞减轻放射性脑损伤的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:石中山
-
依托单位:
E3泛素连接酶Ctl-b通过DBC1/SIRT1轴调控小胶质细胞NLRP3炎性小体在老年PND中的作用及机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈勇
-
依托单位:
AuNPs@CTLA-4/Nb16-Fc多臂纳米抗体增强DC/肿瘤融合疫苗诱导特异性CTL抗癌研究
-
批准号:82360559
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:刘爱群
-
依托单位:
肿瘤细胞微颗粒诱导肥大细胞活化介导CTL细胞耗竭促恶性胸腔积液进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
CTCFL调控IL-10抑制CD4+CTL旁观者激活促口腔鳞状细胞癌新辅助免疫治疗抵抗机制研究
-
批准号:82373325
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:夏荣辉
-
依托单位:
肿瘤细胞TMEM87a介导CTL杀伤抵抗的机制研究
-
批准号:82302075
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李经
-
依托单位:
恶性胸腔积液肿瘤细胞微颗粒中干细胞因子刺激肥大细胞脱颗粒介导CTL细胞耗竭的作用及机制研究
-
批准号:--
-
项目类别:--
-
资助金额:30万元
-
批准年份:2023
-
负责人:张帅
-
依托单位:
具备CTL增强效应的IBV优势表位对清除变异株的作用及机制研究
-
批准号:32302906
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:夏静
-
依托单位: